Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In addition, the characterized LASSS treatment did not stimulate autolysis of HGF as monitored by SDS-PAGE for degradation of 60-kDa -chain and 90-kDa proform of recombinant HGF incubated with LASSS (at 1:8000) at 25 for 2 h (see supplementary Figure 1b), providing another important basis for the availability of LASSS-HGF
Cytoprotective Gastric Pentadecapeptide BPC 157 Resolves Major Vessel Occlusion Disturbances
CJC-1295: Some studies have suggested that CJC-1295 may increase the risk of headache, gastrointestinal disturbances, and vasodilation symptoms, including facial flushing, sensations of warmth, and temporarily lowered blood pressure
For a related benefit area, explore the Immunity collection
BPC-157 typically arrives as lyophilized (freeze-dried) powder in vials of 5 mg, 10 mg, or 20 mg requiring reconstitution with bacteriostatic water
US$ 23.84
US$ 26.10
US$ 26.70
US$ 28.39
US$ 29.49
US$ 21.27
